Latency-associated peptide (LAP)+CD4+ regulatory T cells prevent atherosclerosis by modulating macrophage polarization

Jian Yu,Wenbin Xu,Qian Dong,Qingwei Ji,Min Cheng,Desheng Hu,Yifan Cai,Qiutang Zeng,Kunwu Yu
DOI: https://doi.org/10.1016/j.clim.2023.109767
IF: 10.19
2023-10-01
Clinical Immunology
Abstract:RATIONALE: A persistent autoimmune and inflammatory response plays a critical role in the progression of atherosclerosis. The transcription factor forkhead box P3 (Foxp3)<sup>+</sup>CD4<sup>+</sup> regulatory T cells (Foxp3<sup>+</sup> Tregs) attenuate atherosclerosis. Latency-associated peptide (LAP)<sup>+</sup>CD4<sup>+</sup> T cells are a new class of Tregs whose role in atherosclerosis is unknown.OBJECTIVE: To investigate the function of CD4<sup>+</sup>LAP<sup>+</sup> Tregs in inhibiting inflammation and preventing atherosclerosis.METHODS AND RESULTS: Depletion of CD4<sup>+</sup>LAP<sup>+</sup> Tregs results in aggravated inflammation and atherosclerotic lesions. Mechanistically, CD4<sup>+</sup>LAP<sup>+</sup> Treg depletion was associated with decreased M2-like macrophages and increased Th1 and Th17 cells, characterized by increased unstable plaque promotion and decreased expression of inflammation-resolving factors in both arteries and immune organs. In contrast, adoptive transfer of CD4<sup>+</sup>LAP<sup>+</sup> Tregs to ApoE<sup>-/-</sup> mice or CD4<sup>-/-</sup>ApoE<sup>-/-</sup> mice led to decreased atherosclerotic lesions. Compared with control animals, adoptive transfer of CD4<sup>+</sup>LAP<sup>+</sup> Tregs induced M2-like macrophage differentiation within the atherosclerotic lesion and spleen, associated with increased collagen and α-SMA in plaques and decreased expression of MMP-2 and MMP-9. Mechanistic studies reveal that isolated CD4<sup>+</sup>LAP<sup>+</sup> Tregs exhibit a tolerance phenotype, with increased expression of inhibitory cytokines and coinhibitory molecules. After coculture with CD4<sup>+</sup>LAP<sup>+</sup> Tregs, monocytes/macrophages display typical features of M2 macrophages, including upregulated expression of CD206 and Arg-1 and decreased production of MCP-1, IL-6, IL-1β and TNF-α, which was almost abrogated by transwell and partially TGF-β1 neutralization. RNA-seq analysis showed different gene expression profiles between CD4<sup>+</sup>LAP<sup>+</sup> Tregs and LAP<sup>-</sup>CD4<sup>+</sup> T cells and between CD4<sup>+</sup>LAP<sup>+</sup> Tregs of ApoE<sup>-/-</sup> mice and CD4<sup>+</sup>LAP<sup>+</sup> Tregs of C57BL/6 mice, of which Fancd2 and IL4i1 may contribute to the powerful inhibitory properties of CD4<sup>+</sup>LAP<sup>+</sup> Tregs. Furthermore, the number and the suppressive properties of CD4<sup>+</sup>LAP<sup>+</sup> Tregs were impaired by oxLDL.CONCLUSIONS: Our data indicate that the remaining CD4<sup>+</sup>LAP<sup>+</sup> Tregs play a protective role in atherosclerosis by modulating monocyte/macrophage differentiation and regulatory factors, which may partly explain the protective effect of T cells tolerance in atherosclerosis. Moreover, adoptive transfer of CD4<sup>+</sup>LAP<sup>+</sup> Tregs constitutes a novel approach to treat atherosclerosis.
immunology
What problem does this paper attempt to address?